LKQ Cut EPS to $2.75 After a $50M Europe ERP Mess- Bargain or Trap?

Europe's ERP disruption drove the guidance cut and the selloff

LKQ's full-year adjusted EPS outlook is now $2.60 to $2.90, with a $2.75 midpoint, down from $2.90 to $3.20. The company also said Germany's ERP implementation reduced EBITDA by about $50 million. Investors responded quickly: shares were 12.2% lower at $23.17 in premarket trading and slipped below the $23.98 52-week low. The move suggests the market is no longer willing to pay a predictability premium until it sees a clearer path to recovery.

Management is framing the quarter as a contained execution problem, not a broken business. It said North America returned to positive organic growth and that Specialty also grew. But the market is focusing on Europe, where the ERP disruption appears to have been the main reason expectations were cut.

North America and Specialty still show underlying demand

The key question is whether the damage is isolated to Europe or reflects a broader demand problem. On the face of it, LKQ still looks more like a regional disruption story than a business-wide breakdown.

North America posted 0.5% organic growth in the quarter, its first growth since 2023. Management said that improvement was driven by record alternative-parts utilization of over 40%, moderating insurance premiums, and continued sequential improvement in repairable claims. That matters because it suggests demand is still there, even if it is becoming more selective.

What held up

• North America: The return to organic growth, paired with $207 million of EBITDA on a 14.1% margin, suggests the core operating model is still working.
• Specialty: Organic revenue grew 4.5% even in a challenging end-market environment. Management said that growth came despite macro pressure on consumers, even as margins were affected by an $8 million one-time reserve.

Where Europe broke down

Europe is clearly the problem area. The region's organic revenue declined 12.6%, and Germany's ERP disruption is estimated to have cut revenue by $140 million and EBITDA by $50 million. Management also said Europe still generated $109 million of EBITDA and delivered $40 million in year-over-year cost savings outside the ERP impact. That points to a serious setback, but not a complete breakdown in operations.

What would make LKQ a buy after the reset?

The market is no longer pricing LKQ as a simple "no surprises" stock. After the EPS cut to a $2.75 midpoint and the $50 million EBITDA hit in Europe, the previous 52-week low is no longer a firm floor. Going forward, investors will likely pay up only if Europe shows that the ERP issue was painful but contained.

Signals that support a buy case

• Europe shows a credible recovery from the ERP disruption rather than ongoing execution weakness.
• The stock stabilizes and reclaims $23.98 with follow-through, rather than bouncing once and fading.
• Management ties its recovery narrative to operating milestones, not just "temporary" labels.

What could still make this a trap

• North America or Specialty start to weaken as well, which would imply the problem is broader than Germany.
• Recovery timelines slip and force LKQ to rely more heavily on balance-sheet flexibility.

If Europe does not recover as expected, or if the weaker regions start to spread, the post-earnings reset may have been necessary rather than extreme.